CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

Similarly, analysis of CD70 high versus CD70 low MM patients from the CoMMpass study revealed significant enrichment of genes in the HIF1α pathway and transcriptional networks, with a strong trend toward HIF1α pathway activity (Fig. 3F ).

also in 5,725 other papers